Javascript must be enabled to continue!
SMU‐A inhibits Aβ‐induced NLRP3 inflammasome via autophagy mediated by the AMPK/ULK1 and Raf/MEK/ERK pathways in microglia
View through CrossRef
Accumulation of β‐amyloid (Aβ) and its induced inflammation are recognized as two major pathological features of Alzheimer disease (AD). Autophagy, an intracellular catabolic mechanism, plays a pivotal role in neurodegenerative disease for degrading the toxic aggregated proteins such as Aβ, α‐Synuclein and mHtt. Recently, autophagy activation in microglia was reported to not only degrade extracellular Aβ fribils but also inhibit Aβ‐induced NLRP3 inflmmasome. In the present experiment, the potential autophagy inducers from SMU, a traditional Chinese medicine, were identified in microglial cells (BV‐2) by using column chromatography, UHPLC‐TOF/MS and NMR technologies. Total four ellagitannin flavonoids including SMU‐A, SMU‐B, SMU‐C and SMU‐D were identified, and SMU‐A was proved to possess the best autophagic effect in BV‐2 cells. Furthermore, the autophagy was activated through the AMPK/ULK1, Raf/MEK/ERK and ATG7 dependent, but independent of mTOR signaling pathway. In Aβ1‐42 induced BV‐2 cells, SMU‐A inhibits inflammasome containing NLRP3, ASC, IL‐1β and caspase1 via autophagy, which was reversed by the autophagic inhibitors such as compound C, SCH772984, hydroxychloroquine and SBI‐0206965. Additionally, SMU‐A can improve cell viability of PC12 induced injury by cell culture medium of Aβ‐induced BV‐2. Taken together, enhanced microglial autophagy is a promising new therapeutic strategy for AD, and demonstrate the autophagy inducers in SMU exerts the potential neuroprotective mechanism in suppressing neuroinflammatory responses by enhancing autophagy in microglial. Therefore, uncovering the components in SMU contributing to autophagy activation and its molecular mechanism provide new insight of PCP into novel therapies for the amelioration of AD.
Support or Funding Information
The Science and Technology Program of Luzhou” (grant numbers 2016LZXNYD‐T03 and 2017LZXNYD‐J28), “Educational Commission of Sichuan Province” (grant numbers 18ZA0528 and 18TD0051), “Science and Technology Planning Project of Sichuan Province” (grant numbers 2018JY0474 and 2018JY0237)
This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in
The FASEB Journal
.
Title: SMU‐A inhibits Aβ‐induced NLRP3 inflammasome via autophagy mediated by the AMPK/ULK1 and Raf/MEK/ERK pathways in microglia
Description:
Accumulation of β‐amyloid (Aβ) and its induced inflammation are recognized as two major pathological features of Alzheimer disease (AD).
Autophagy, an intracellular catabolic mechanism, plays a pivotal role in neurodegenerative disease for degrading the toxic aggregated proteins such as Aβ, α‐Synuclein and mHtt.
Recently, autophagy activation in microglia was reported to not only degrade extracellular Aβ fribils but also inhibit Aβ‐induced NLRP3 inflmmasome.
In the present experiment, the potential autophagy inducers from SMU, a traditional Chinese medicine, were identified in microglial cells (BV‐2) by using column chromatography, UHPLC‐TOF/MS and NMR technologies.
Total four ellagitannin flavonoids including SMU‐A, SMU‐B, SMU‐C and SMU‐D were identified, and SMU‐A was proved to possess the best autophagic effect in BV‐2 cells.
Furthermore, the autophagy was activated through the AMPK/ULK1, Raf/MEK/ERK and ATG7 dependent, but independent of mTOR signaling pathway.
In Aβ1‐42 induced BV‐2 cells, SMU‐A inhibits inflammasome containing NLRP3, ASC, IL‐1β and caspase1 via autophagy, which was reversed by the autophagic inhibitors such as compound C, SCH772984, hydroxychloroquine and SBI‐0206965.
Additionally, SMU‐A can improve cell viability of PC12 induced injury by cell culture medium of Aβ‐induced BV‐2.
Taken together, enhanced microglial autophagy is a promising new therapeutic strategy for AD, and demonstrate the autophagy inducers in SMU exerts the potential neuroprotective mechanism in suppressing neuroinflammatory responses by enhancing autophagy in microglial.
Therefore, uncovering the components in SMU contributing to autophagy activation and its molecular mechanism provide new insight of PCP into novel therapies for the amelioration of AD.
Support or Funding Information
The Science and Technology Program of Luzhou” (grant numbers 2016LZXNYD‐T03 and 2017LZXNYD‐J28), “Educational Commission of Sichuan Province” (grant numbers 18ZA0528 and 18TD0051), “Science and Technology Planning Project of Sichuan Province” (grant numbers 2018JY0474 and 2018JY0237)
This abstract is from the Experimental Biology 2019 Meeting.
There is no full text article associated with this abstract published in
The FASEB Journal
.
Related Results
The Transcription Factor Gfi1 Negatively Regulates NLRP3 inflammasome-Mediated IL-1β Secretion in Macrophages
The Transcription Factor Gfi1 Negatively Regulates NLRP3 inflammasome-Mediated IL-1β Secretion in Macrophages
Abstract
Background: IL-1β secretion is tightly controlled at the transcriptional and post-translational levels. The NLRP3 inflammasome, a multiprotein complex compo...
Iron Restriction Alleviates β-Thalassemia By Stimulating ULK1-Mediated Autophagy of Free α-Globin
Iron Restriction Alleviates β-Thalassemia By Stimulating ULK1-Mediated Autophagy of Free α-Globin
In β-thalassemia, mutations in the HBB gene cause reduced β-globin synthesis with accumulation of toxic free α-globin, leading to ineffective erythropoiesis and hemolysis. We showe...
Loss of AMPK potentiates inflammation by activating the inflammasome after traumatic brain injury in mice
Loss of AMPK potentiates inflammation by activating the inflammasome after traumatic brain injury in mice
AbstractTraumatic brain injury (TBI) is a significant public health concern characterized by a complex cascade of cellular events. TBI induces adenosine monophosphate-activated pro...
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection
Abstract
S3.4 Free oral paper session, September 21, 2022, 4:45 PM - 6:15 PM
Talaromyces (Penicillium) marneffei (T. marneffei) ...
RACK1 mediates NLRP3 inflammasome activation during Pasteurella multocida infection
RACK1 mediates NLRP3 inflammasome activation during Pasteurella multocida infection
Abstract
Pasteurella multocida is gram-negative bacteria that causes serious diseases in a wide range of animal species. Inflammasome as an intracellular multimolecular pro...
RACK1 mediates NLRP3 inflammasome activation during Pasteurella multocida infection
RACK1 mediates NLRP3 inflammasome activation during Pasteurella multocida infection
Abstract
Pasteurella multocida
is a gram-negative bacterium that causes serious diseases in a wide range of animal specie...
Abstract A31: Germline RASopathy mutations provide functional insights into the Raf cysteine-rich domain (CRD)
Abstract A31: Germline RASopathy mutations provide functional insights into the Raf cysteine-rich domain (CRD)
Abstract
The three-member RAF kinase family (A-, B- and C-Raf) are direct Ras effectors and key mediators of the proproliferative MAPK pathway. Somatic driver mutati...
Stress granule component protein TIA1 is a negative regulator of the noncanonical NLRP3 inflammasome
Stress granule component protein TIA1 is a negative regulator of the noncanonical NLRP3 inflammasome
Abstract
Inflammasomes are cytosolic signaling hubs assembled upon pathogen- or damage-associated molecular pattern (PAMP and DAMP) sensing by innate immune patte...

